- Report
- September 2021
- 212 Pages
Global
From €2404EUR$2,598USD£2,022GBP
€3434EUR$3,712USD£2,888GBP
- Report
- March 2022
- 270 Pages
Global
From €2404EUR$2,598USD£2,022GBP
€3434EUR$3,712USD£2,888GBP
- Report
- May 2022
- 256 Pages
Global
From €2238EUR$2,419USD£1,882GBP
€3197EUR$3,456USD£2,689GBP
- Book
- July 2022
- 400 Pages
- Book
- August 2021
- 312 Pages
- Book
- March 2024
- 400 Pages
- Book
- October 2023
- 464 Pages
- Book
- March 2022
- 896 Pages
- Book
- November 2013
- 744 Pages
- Book
- October 2012
- 400 Pages
- Book
- July 2010
- 376 Pages
- Book
- May 2021
- 1488 Pages
Global
- Book
- September 2024
- 352 Pages

The Hormone Drug market is a subset of the biotechnology industry that focuses on the development and production of drugs that target hormones. These drugs are used to treat a variety of conditions, including diabetes, obesity, infertility, and menopause. Hormone drugs are typically administered through injections, patches, or pills, and are designed to mimic the body's natural hormones.
The hormone drug market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing ones. Additionally, many companies are investing in research and development to create more effective treatments.
Notable companies in the hormone drug market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more